NCT00004604View on ClinicalTrials.gov

Biological Therapy in Treating Patients With Metastatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 1997

Primary Completion Date

June 30, 2001

Study Completion Date

July 31, 2002

Conditions
Breast CancerColorectal CancerExtrahepatic Bile Duct CancerGallbladder CancerGastric CancerHead and Neck CancerLiver CancerLung CancerMetastatic CancerOvarian CancerPancreatic CancerTesticular Germ Cell Tumor
Interventions
BIOLOGICAL

CEA RNA-pulsed DC cancer vaccine

carcinoembryonic antigen RNA-pulsed dendritic cells

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER